Research & Education
CURE Expert Connections
To start your customized experience click the start button
Cancer of Unknown Primary
Diet and Exercise
Gastrointestinal stromal tumor
General Financial Topics
General Psychosocial Aspect Topics
Head & Neck Cancer
MDS and MPN
Side Effect Management
Advocacy & Research
Share Your Story
Newsletter Sign Up
Ovarian Cancer Heroes
Terms & Conditions
Cure Media Group, LLC.
2 Clarke Drive
Cranbury, NJ 08512
Copyright © 2017
CURE Communications Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Combination Improves Progression-Free Survival in Lung Cancer
The combination delated progression or death compared to Avastin and chemotherapy alone, according to Roche, the manufacturer of the anti–PD-L1 and anti–VEGF agents.
Telehealth Can Expand Lung Cancer Treatment Options in Rural Areas
M. CLARK, M.D., AND ELIZABETH A. DAVID, M.D., MAS, FACS
Rural patients tend to have diminished access to appropriate, routine cancer screening studies, leading to patients with cancer being diagnosed with more advanced stage disease.
Novel Drug Combination Hits Non-Small Cell Lung Cancer With Double Punch
For patients with advanced disease, median survival was improved.
Weighing Costs and Consequences of Cancer Care Settings
A recent study found that the cost to patients with breast, lung and colorectal cancers treated in the hospital outpatient setting was nearly $8,000 more than those treated in the community setting.
Approaching Lung Cancer With Precision
New targeted therapies are rapidly changing the landscape of non-small cell lung cancer.
Liquid Biopsies: A Lung Cancer Game-Changer?
Newer, less invasive tests are helping scientists isolate genomic alterations.
Examining the Relationship Between Stress and Lung Cancer
When her fears came true in 2005, Feldman couldn’t help but wonder whether all that stress contributed to her own non-small cell lung cancer (NSCLC) diagnosis.
Treatment for EGFR-Mutant Lung Cancer Is Rapidly Expanding
There has been a “renaissance” in the treatment strategies of patients with non-small cell lung cancer (NSCLC) who have EGFR-mutation–positive disease, Edward S. Kim, M.D.
Expert Discusses Immunotherapy's Expanding Role in Lung Cancer Treatment
Marina C. Garassino, M.D., talks about exciting advances in the field of lung cancer.
Cancer Solace in Strange Places
A patient with metastatic breast cancer discusses what helps her find comfort.
Not a member?
Sign up now!
Continue without login
OPTIONAL INFORMATION: The following information helps us tailor CURE to fit your needs
Please type below what best describes your interests and click on the selection(s):
What is your status?
Out of Treatment